Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/14528090

Download in:

View as

General Info

PMID
14528090